Form 4 for NVAX NOVAVAX INC
Accepted 2021-12-15 00:00:00 ET · period of report 2021-12-13 · accession 0001209191-21-069798 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-15 | 2021-12-13 | NVAX | DOUGLAS RICHARD | Dir | M - OptEx | $25.60 | +1,500 | 33.5K | +5% | +$38.4K |
| D | 2021-12-15 | 2021-12-13 | NVAX | DOUGLAS RICHARD | Dir | M - OptEx | $0.00 | -1,500 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-13 | M | A | 1,500 | $25.60 | 33,450 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-12-13 | M | D | 1,500 | $0.00 | 0 | D | $25.60 · 2012-09-01 to 2022-03-01 | 1,500 Common Stock |